October 01, 2014 10:49 PM ET

Pharmaceuticals

Company Overview of Actavis Pharma Inc.

Executive Profile

Martin Sperber

Chief Executive Officer, Chairman, and President, Schein Pharmaceutical PA, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

82--

Background

Mr. Martin Sperber was the Chief Executive Officer and Chairman of the Board of Actavis Pharma Inc. He is a member of the board of Directors of Long Island University and a member of the council of overseers of the Long Island University Arnold and Marie Schwartz College of Pharmacy and a member of the American Pharmaceutical Association. He served as a member of the boards of the Generic Pharmaceutical Industry Association and American Foundation For Pharmaceutical ...

Corporate Headquarters

100 Campus Drive
Florham Park, New Jersey 07932

United States

Phone: 201-593-5500
Fax: 201-593-5590

Board Members Memberships

Chief Executive Officer, Chairman, and President
1989-N/A
Chief Executive Officer and Chairman
2002-N/A
Former Director

Education

BS
Columbia University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Actavis Pharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.